Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 3.00% is 77% below its 5-year average of 13.17%, near the low end of its 5-year range (1.38%–47.68%).
As of the fiscal period ended Tuesday, June 30, 2026. 14.98% below its 12-month average of 3.53%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.00%.
DEBT TO ASSETS RATIO
3.00%
DEBT TO ASSETS RATIO AVG TTM
3.53%
DEBT TO ASSETS RATIO AVG 3Y
3.46%
DEBT TO ASSETS RATIO AVG 5Y
13.17%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-14.98%
CURRENT VS 3Y AVG
-13.19%
CURRENT VS 5Y AVG
-77.22%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+3233.02%
vs the sector median at left
RxSight, Inc.
Market Cap
$192.29M
Debt to Assets Ratio
3.00%
TTM Avg
3.53%
3Y Avg
3.46%
5Y Avg
13.17%
Market Cap
$193.27M
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$189.50M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$184.94M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$183.69M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$183.55M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| RxSight, Inc. (RXST) | $192.29M | 3.00% | 3.53% | 3.46% | 13.17% |
| Zentalis Pharmaceuticals, Inc. (ZNTL)vs › | $193.27M | 0.18% | N/A | N/A | N/A |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.50M | 0.00% | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $184.94M | 0.00% | N/A | N/A | N/A |
| Surrozen, Inc. (SRZN)vs › | $199.87M | 0.05% | N/A | N/A | N/A |
| Alector, Inc. (ALEC)vs › | $200.40M | 0.16% | N/A | N/A | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $183.69M | 0.05% | N/A | N/A | N/A |
| Canton Strategic Holdings Inc (CNTN)vs › | $183.55M | 0.00% | N/A | N/A | N/A |
| Exagen Inc. (XGN)vs › | $202.11M | 0.49% | N/A | N/A | N/A |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $181.30M | 0.00% | N/A | N/A | N/A |
Debt/Assets
3.0%
Debt/Equity
0.04
Current Ratio
4.07
Interest Coverage
-1204.8x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 3.00% |
| 2026-03-31 | 3.56% |
| 2025-12-31 | 3.54% |
| 2025-09-30 | 3.75% |
| 2025-06-30 | 3.79% |
| 2025-03-31 | 3.85% |
| 2024-12-31 | 3.86% |
| 2024-09-30 | 3.64% |
| 2024-06-30 | 3.73% |
| 2024-03-31 | 1.38% |
| 2023-12-31 | 1.65% |
| 2023-09-30 | 1.83% |
| 2023-06-30 | 11.99% |
| 2023-03-31 | 22.03% |
| 2022-12-31 | 29.96% |
| 2022-09-30 | 29.11% |
| 2022-06-30 | 27.34% |
| 2022-03-31 | 25.36% |
| 2021-12-31 | 23.31% |
| 2021-09-30 | 22.16% |
| 2021-06-30 | 47.68% |
| 2021-03-31 | 36.89% |
| 2020-12-31 | 30.55% |
